Autism and Epilepsy: Practical points that clinicians should aware of
Main Article Content
Abstract
A 15-year-old high functioning autistic boy with normal IQ was found to have episode of eyes rolling upwards followed by rhythmic body shaking and was unresponsive for 2 minutes
Article Details
How to Cite
1.
Saengpattrachai M. Autism and Epilepsy: Practical points that clinicians should aware of. BKK Med J [Internet]. 2011 Feb. 18 [cited 2024 Oct. 13];1(1):106. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/217684
Issue
Section
Continue Medical Education (CME)
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association 2000;1943(2):217-250
2. Rapin I. The autistic-spectrum disorders. N Engl J Med 2002;347:302-303
3. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-250
4. Barbaresi WJ, Katusic SK, Voigt RG. Autism: A review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med 2006; 160:1167-1175
5. Fombonne E: Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365-382
6. Landa RJ, Holman KC, Garrett-Mayer E. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry 2007;64:853-864
7. Fombonne E, Zakarian R, Bennett A, et al. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:139-150
8. Rapin I, Tuchman RF. What is new in autism? Curr Opin Neurol 2008;21:143-149
9. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nature Genet 2008;9:341-355
10. Zimmerman AW, Connors SL, Matteson KJ, et al. Maternal antibrain antibodies in autism. Brain Behav Immun 2007;21:351-357
11. Garber K. Neuroscience: autism’s cause may reside in abnormalities at the synapse.Science 2007; 317:190-191
12. Crawley JN. Testing hypotheses about autism. Science 2007;318:56-57
13. Casanova MF. Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist 2006;12:435-441
14. Tuchman RF, Rapin I. Epilepsy in autism. Lancet Neurol 2002;1:352-358
15. Volkmar FR, Nelson DS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990;29:127-129
16. Steffenburg S, Gillberg C, Steffenburg U. Psychiatric disorders in children and adolescents with mental retar- dation and active epilepsy. Arch Neurol 1996;53:904-912
17. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children, II: epilepsy. Pediatrics 1991;88:1219-1225
18. Binnie C, Channon S, Marston D. Behavioural correlates of interictal spikes. In: Smith D, Treiman D, Trimble M, eds. Neurobehavioural correlates of epilepsy. New York:Raven Press, 1991:113-126
19. Scott RC, Neville BG. Developmental perspectives on epilepsy. Curr Opin Neurol 1998;I1:115-118
20. Chez MG, Chang M, Krasne V, et al. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 2006;267-271
21. Small JG: EEG and neurophysiological studies of early infantile autism. Biol Psychiatry 1975;10:385-397
22. Kobayashi R, Murata T. Setback phenomenon in autism and long-term prognosis. Acta Psychiatr Scand 1998;98:296-303
23. Ballaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: Association with autism and languaged disorders. Ment Retard Dev Disabil Res Rev 2000;6:300-308
24. Gillberg C. The treatment of epilepsy in autism. J Autism Dev Disord 1991;21:61-77
25. Glauser TA. Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy. Epilepsy Behav 2004;5:25-32
26. Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990;31:768-777
27. Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet immunoglobulins, and steroids. Epilepsia 1996;37(suppl 1):81-95
28. Lagae LG, Silberstein J, Gillis PL, Casaer PJ. Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome. Pediatr Neurol 1998;18:165-168
29. Mikati MA, Saab R. Successful use of intravenous immunoglobulin as initial monotherapy in Lan- dau-Kleffner syndrome. Epilepsia 2000;41:880-886
30. Tsuru T, Mori M, Mizuguchi M, Momoi MY. Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome. Pediatr Neurol 2000;22:145-147
31. Nass R, Petrucha D. Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant. J Child Neurol 1990;5:327-328
32. Plioplys AV. Autism: electroencephalogram abnor- malities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 1994;148:220-222
33. Childs JA, Blair JL. Valproic acid treatment of epilepsy in autistic twins. J Neurosci Nurs 1997;29:244-248
34. Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry 2001;62:530-534
35. Neville BG, Harkness WF, Cross JH, et al. Surgical treatment of severe autistic regression in childhood epilepsy. Pediatr Neurol 1997;16:137-140
36. Nass R, Gross A, Wisoff J, Devinsky O. Outcome of multiple subpial transections for autistic epilepti- form regression. Pediatr Neurol 1999;21:464-470
37. Szabo CA, Wyllie E, Dolske M, Stanford LD, Kotagal P, Comair YG. Epilepsy surgery in children with pervasive developmental disorder. Pediatr Neurol 1999;20:349-353
38. Lewine JD, Andrews R, Chez M, et al. Magnetoen- cephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 1999;104:405-418
2. Rapin I. The autistic-spectrum disorders. N Engl J Med 2002;347:302-303
3. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-250
4. Barbaresi WJ, Katusic SK, Voigt RG. Autism: A review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med 2006; 160:1167-1175
5. Fombonne E: Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365-382
6. Landa RJ, Holman KC, Garrett-Mayer E. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry 2007;64:853-864
7. Fombonne E, Zakarian R, Bennett A, et al. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:139-150
8. Rapin I, Tuchman RF. What is new in autism? Curr Opin Neurol 2008;21:143-149
9. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nature Genet 2008;9:341-355
10. Zimmerman AW, Connors SL, Matteson KJ, et al. Maternal antibrain antibodies in autism. Brain Behav Immun 2007;21:351-357
11. Garber K. Neuroscience: autism’s cause may reside in abnormalities at the synapse.Science 2007; 317:190-191
12. Crawley JN. Testing hypotheses about autism. Science 2007;318:56-57
13. Casanova MF. Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist 2006;12:435-441
14. Tuchman RF, Rapin I. Epilepsy in autism. Lancet Neurol 2002;1:352-358
15. Volkmar FR, Nelson DS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990;29:127-129
16. Steffenburg S, Gillberg C, Steffenburg U. Psychiatric disorders in children and adolescents with mental retar- dation and active epilepsy. Arch Neurol 1996;53:904-912
17. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children, II: epilepsy. Pediatrics 1991;88:1219-1225
18. Binnie C, Channon S, Marston D. Behavioural correlates of interictal spikes. In: Smith D, Treiman D, Trimble M, eds. Neurobehavioural correlates of epilepsy. New York:Raven Press, 1991:113-126
19. Scott RC, Neville BG. Developmental perspectives on epilepsy. Curr Opin Neurol 1998;I1:115-118
20. Chez MG, Chang M, Krasne V, et al. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 2006;267-271
21. Small JG: EEG and neurophysiological studies of early infantile autism. Biol Psychiatry 1975;10:385-397
22. Kobayashi R, Murata T. Setback phenomenon in autism and long-term prognosis. Acta Psychiatr Scand 1998;98:296-303
23. Ballaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: Association with autism and languaged disorders. Ment Retard Dev Disabil Res Rev 2000;6:300-308
24. Gillberg C. The treatment of epilepsy in autism. J Autism Dev Disord 1991;21:61-77
25. Glauser TA. Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy. Epilepsy Behav 2004;5:25-32
26. Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990;31:768-777
27. Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet immunoglobulins, and steroids. Epilepsia 1996;37(suppl 1):81-95
28. Lagae LG, Silberstein J, Gillis PL, Casaer PJ. Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome. Pediatr Neurol 1998;18:165-168
29. Mikati MA, Saab R. Successful use of intravenous immunoglobulin as initial monotherapy in Lan- dau-Kleffner syndrome. Epilepsia 2000;41:880-886
30. Tsuru T, Mori M, Mizuguchi M, Momoi MY. Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome. Pediatr Neurol 2000;22:145-147
31. Nass R, Petrucha D. Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant. J Child Neurol 1990;5:327-328
32. Plioplys AV. Autism: electroencephalogram abnor- malities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 1994;148:220-222
33. Childs JA, Blair JL. Valproic acid treatment of epilepsy in autistic twins. J Neurosci Nurs 1997;29:244-248
34. Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry 2001;62:530-534
35. Neville BG, Harkness WF, Cross JH, et al. Surgical treatment of severe autistic regression in childhood epilepsy. Pediatr Neurol 1997;16:137-140
36. Nass R, Gross A, Wisoff J, Devinsky O. Outcome of multiple subpial transections for autistic epilepti- form regression. Pediatr Neurol 1999;21:464-470
37. Szabo CA, Wyllie E, Dolske M, Stanford LD, Kotagal P, Comair YG. Epilepsy surgery in children with pervasive developmental disorder. Pediatr Neurol 1999;20:349-353
38. Lewine JD, Andrews R, Chez M, et al. Magnetoen- cephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 1999;104:405-418